| JYHB2100230 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2021-03-31 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | In Review | 2021-03-30 | view |
| JYHZ2300459 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | License Renew | 2023-12-21 | | | | | view |
| CYHS2403164 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-09-25 | | Hangzhou Zhuyangxin Pharmaceutical Co Ltd | | | view |
| JXHS2300005 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-01-07 | | | | | view |
| CYHS2401661 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-06-04 | | Nanjing Healthnice Pharmaceutical Co Ltd | | | view |
| JYHB2000732 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-06-06 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-06-16 | view |
| CYHS2302467 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-09-13 | | | | | view |
| CYHS2403163 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-09-25 | | Hangzhou Zhuyangxin Pharmaceutical Co Ltd | | | view |
| JXHS2300006 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-01-07 | | | | | view |
| CYHS2401543 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-05-23 | | Wanbang Biopharmaceuticals | | | view |
| JYHB2000582 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-05-13 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-05-25 | view |
| CYHS2101450 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2021-08-03 | | | | | view |
| CYHS2403044 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-09-12 | | Anhui Taienkang Pharmaceutical Co Ltd | | | view |
| JYHB2001161 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-07-04 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-12-10 | view |
| JXHS2200004 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-01-10 | | | | | view |
| CYHS2401544 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-05-23 | | Wanbang Biopharmaceuticals | | | view |
| JYHB2000084 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-01-22 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-02-17 | view |
| JXHS2200003 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-01-10 | | | | | view |
| JYHB2300401 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2023-07-18 | | | | | view |
| JYHB2100231 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2021-03-31 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | In Review | 2021-03-30 | view |
